Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas' lawsuit demanding credit for inventions ...
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants ...
CureVac and Acuitas Therapeutics have settled their COVID-19 vaccine dispute. According to a filing, submitted April 25, 2024 ...
In 2022, CureVac sued rival BioNTech for patent infringement, claiming some of that company’s success in COVID-19 was based on CureVac’s intellectual property. Litigation between the two ...
GSK said in the lawsuit , opens new tab that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the ...
%3Ciframe%20thumb%3D%22https%3A%2F%2Fwww.aclu.org%2Fsites%2Fdefault%2Ffiles%2Fstyles%2Fvideo_thumbnail_1030x580%2Fpublic%2Ffield_image%2Femvideo-youtube-xsworp-y3a8 ...
CureVac is asserting its intellectual property rights in litigation against Pfizer/BioNTech in Germany, the U.S. and the UK. In the U.S., a magistrate judge recently granted a motion by Acuitas ...
Stephane Cardinale - Corbis/Corbis via Getty; Theo Wargo/Getty David Beckham's Oct. 2022 lawsuit against Mark Wahlberg's fitness company F45 for breach of contract is bubbling up again this week ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Benzinga - by Vandana Singh, Benzinga Editor. Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV (NASDAQ:CVAC) have settled Acuitas’ lawsuit over credit for inventions tied to ...
GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...